文献速递贫血与红细胞疾病

获得性再生障碍性贫血中HLA缺失与GPI锚定蛋白缺失造血干祖细胞的差异

Hematopoietic stem progenitor cells lacking HLA differ from those lacking GPI-anchored proteins in the hierarchical stage and sensitivity to immune attack in patients with acquired aplastic anemia.
PubMed 文献 · Leukemia · 2021-04-06

该研究分析56例缓解期获得性再生障碍性贫血患者外周血,比较HLA class I等位基因缺失(HLA[-])与GPI锚定蛋白缺失(GPI[-])造血干祖细胞。发现HLA[-]细胞累及所有外周血细胞谱系的比例更高,且HLA[-]粒细胞中位比例显著高于GPI[-]粒细胞;纵向观察提示两类细胞对免疫攻击敏感性及分化阶段不同。

要点

  • HLA[-]细胞比GPI[-]细胞累及更多血细胞谱系,包括血小板。
  • HLA[-]粒细胞中位比例21.2%,显著高于GPI[-]粒细胞0.28%。
  • 两类细胞在分化阶段和对免疫攻击敏感性上存在差异。

核心结论

  • HLA[-]造血干祖细胞与GPI[-]造血干祖细胞在分化阶段和对免疫攻击的敏感性上不同。

研究设计与样本

  • 研究纳入56例缓解期获得性再生障碍性贫血患者外周血,其中13例同时存在两类细胞(A组),34例仅GPI[-](B组),9例仅HLA[-](C组)。

主要发现

  • A组HLA[-]粒细胞占总粒细胞的中位百分比为21.2%,显著高于GPI[-]粒细胞的0.28%(P < 0.05)。
  • B组与C组比较同样显示HLA[-]细胞谱系多样性高于GPI[-]细胞。
  • A组7例纵向观察:4例对环孢素(CsA)有反应者HLA[-]粒细胞比例逐渐下降、GPI[-]粒细胞比例相应升高;3例持续停用CsA缓解者HLA[-]粒细胞升高而GPI[-]粒细胞稳定或下降。

临床怎么用

  • 在获得性再生障碍性贫血缓解期可检测HLA[-]与GPI[-]细胞群,辅助评估免疫攻击状态及治疗反应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

To characterize glycosylphosphatidylinositol-anchored protein-deficient (GPI[-]) and HLA-class I allele-lacking (HLA[-]) hematopoietic stem progenitor cells (HSPCs) in acquired aplastic anemia (AA), we studied the peripheral blood (PB) of 56 AA patients in remission who possessed both (n = 13, Group A) or either GPI(-) (n = 34, Group B) and HLA(-) (n = 9, Group C) cell populations. Seventy-seven percent (10/13) of Group A had HLA(-) cells in all lineages of PB cells, including platelets, while only 23% (3/13) had GPI(-) cells in all lineages, and the median percentage of HLA(-) granulocytes in the total granulocytes (21.2%) was significantly higher than that of GPI(-) granulocytes (0.28%, P < 0.05). The greater lineage diversity in HLA(-) cells than in GPI(-) cells was also seen when Group B and Group C were compared. Longitudinal studies of seven patients in Group A showed a gradual decrease in the percentage of HLA(-) granulocytes, with a reciprocal increase in the GPI(-) granulocytes in four patients responding to cyclosporine (CsA) and an increase in the HLA(-) granulocytes with a stable or declining GPI(-) granulocytes in three patients in sustained remission off CsA therapy. These findings suggest that HLA(-) HSPCs differ from GPI(-) HSPCs in the hierarchical stage and sensitivity to immune attack in AA.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Yoroidaka T, Hosokawa K, Imi T, et al. Hematopoietic stem progenitor cells lacking HLA differ from those lacking GPI-anchored proteins in the hierarchical stage and sensitivity to immune attack in patients with acquired aplastic anemia. Leukemia. 2021. PMID: 33824463. doi:10.1038/s41375-021-01202-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。